Effects of urolithin A on osteoclast differentiation induced by receptor activator of nuclear factor-κB ligand via bone morphogenic protein 2

References

• Song C, Yang X, Lei Y, et al. Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells. J Cell Physiol. 2019;234(7):11969–11975.
   PubMed Web of Science ®Google Scholar
• Kim JM, Lin C, Stavre Z, et al. Osteoblast-osteoclast communication and bone homeostasis. Cells. 2020;9(9):2073.
   PubMed Web of Science ®Google Scholar
• Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337–342.
   PubMed Web of Science ®Google Scholar
• Gosch M, Kammerlander C, Nicholas JA. Treatment of osteoporosis in older adults. Panminerva Med. 2014;56(2):133–143.
   PubMed Web of Science ®Google Scholar
• Yun H, Delzell E, Saag KG, et al. Fractures and mortality in relation to different osteoporosis treatments. Clin Exp Rheumatol. 2015;33(3):302–309.
   PubMed Web of Science ®Google Scholar
• Shao H, Wu R, Cao L, et al. Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis. Bioengineered. 2021;12(1):960–968.
   PubMed Web of Science ®Google Scholar
• Noh JY, Yang Y, Jung H. Molecular mechanisms and emerging therapeutics for osteoporosis. Int J Mol Sci. 2020;21(20):7623.
   PubMed Web of Science ®Google Scholar
• Saha P, Yeoh BS, Singh R, et al. Gut microbiota conversion of dietary ellagic acid into bioactive phytoceutical urolithin a inhibits heme peroxidases. PLoS One. 2016;11(6):e0156811.
   PubMed Web of Science ®Google Scholar
• Norden E, Heiss EH. Urolithin A gains in antiproliferative capacity by reducing the glycolytic potential via the p53/TIGAR axis in colon cancer cells. Carcinogenesis. 2019;40(1):93–101.
   PubMed Web of Science ®Google Scholar
• Andreux PA, Blanco-Bose W, Ryu D, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat Metab. 2019;1(6):595–603.
   PubMedGoogle Scholar
• Ding SL, Pang ZY, Chen XM, et al. Urolithin a attenuates IL-1beta-induced inflammatory responses and cartilage degradation via inhibiting the MAPK/NF-kappaB signaling pathways in rat articular chondrocytes. J Inflamm (Lond). 2020;17(1):13.
   PubMed Web of Science ®Google Scholar
• Lin J, Zhuge J, Zheng X, et al. Urolithin A-induced mitophagy suppresses apoptosis and attenuates intervertebral disc degeneration via the AMPK signaling pathway. Free Radic Biol Med. 2020;150:109–119.
   PubMed Web of Science ®Google Scholar
• Kukita T, Wada N, Kukita A, et al. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med. 2004;200(7):941–946.
   PubMed Web of Science ®Google Scholar
• Liou YM, Chan CL, Huang R, et al. Effect of l-caldesmon on osteoclastogenesis in RANKL–induced RAW264.7 cells. J Cell Physiol. 2018;233(9):6888–6901.
   PubMed Web of Science ®Google Scholar
• Weitzmann MN. Bone and the Immune System. Toxicol Pathol. 2017;45(7):911–924.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhu G, Jin T, et al. Cadmium induces differentiation of RAW264.7 cells into osteoclasts in the presence of RANKL. Food Chem Toxicol. 2011;49(9):2392–2397.
   PubMed Web of Science ®Google Scholar
• Zamani M, Zamani V, Heidari B, et al. Prevalence of osteoporosis with the World Health Organization diagnostic criteria in the Eastern mediterranean region: a systematic review and meta-analysis. Arch Osteoporos. 2018;13(1):129.
   PubMed Web of Science ®Google Scholar
• Tian Y, Gong Z, Zhao R, et al. Melatonin inhibits RANKLinduced osteoclastogenesis through the miR882/Reverbalpha axis in Raw264.7 cells. Int J Mol Med. 2021;47(2):633–642.
   PubMedGoogle Scholar
• Fujimoto M, Mano Y, Anai M, et al. Epigenetic alteration to activate Bmp2-Smad signaling in Raf-induced senescence. World J Biol Chem. 2016;7(1):188–205.
   PubMedGoogle Scholar
• Qiao H, Wang YF, Yuan WZ, et al. Silencing of ENO1 by shRNA inhibits the proliferation of gastric cancer cells. Technol Cancer Res Treat. 2018;17:1533033818784411.
   Web of Science ®Google Scholar
• Qiu N, Zhou H, Xiao Z. Downregulation of PKD1 by shRNA results in defective osteogenic differentiation via cAMP/PKA pathway in human MG-63 cells. J Cell Biochem. 2012;113(3):967–976.
   PubMed Web of Science ®Google Scholar
• Fu Y, Hu X, Gao Y, et al. LncRNA ROR/miR-145-5p axis modulates the osteoblasts proliferation and apoptosis in osteoporosis. Bioengineered. 2021;12(1):7714–7723.
   PubMed Web of Science ®Google Scholar
• Deng Y, Tong J, Shi W, et al. Thromboangiitis obliterans plasma-derived exosomal miR-223-5p inhibits cell viability and promotes cell apoptosis of human vascular smooth muscle cells by targeting VCAM1. Ann Med. 2021;53(1):1129–1141.
   PubMed Web of Science ®Google Scholar
• Yang H, Zhou J, Wang J, et al. Circulating exosomal MicroRNA profiles associated with acute soft tissue injury. Cell J. 2021;23(4):474–484.
   PubMed Web of Science ®Google Scholar
• Mei L, Li M, Zhang T. MicroRNA miR-874-3p inhibits osteoporosis by targeting leptin (LEP). Bioengineered. 2021;12(2):11756–11767.
   PubMed Web of Science ®Google Scholar
• Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017;5(11):898–907.
   PubMed Web of Science ®Google Scholar
• Fu X, Gong LF, Wu YF, et al. Urolithin A targets the PI3K/Akt/NF-κB pathways and prevents IL-1β-induced inflammatory response in human osteoarthritis: in vitro and in vivo studies. Food Funct. 2019;10(9):6135–6146.
   PubMed Web of Science ®Google Scholar
• Spilmont M, Leotoing L, Davicco MJ, et al. Pomegranate peel extract prevents bone loss in a preclinical model of osteoporosis and stimulates osteoblastic differentiation in vitro. Nutrients. 2015;7(11):9265–9284.
   PubMed Web of Science ®Google Scholar
• Hartman RE, Shah A, Fagan AM, et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer’s disease. Neurobiol Dis. 2006;24(3):506–515.
   PubMed Web of Science ®Google Scholar
• Chen P, Chen F, Lei J, et al. Activation of the miR-34a-mediated SIRT1/mTOR signaling pathway by urolithin A attenuates D-galactose-induced brain aging in mice. Neurotherapeutics. 2019;16(4):1269–1282.
   PubMed Web of Science ®Google Scholar
• Lin Z, Huang S, and LingHu X, et al. Perillaldehyde inhibits bone metastasis and receptor activator of nuclear factor-kappaB ligand (RANKL) signaling-induced osteoclastogenesis in prostate cancer cell lines. Bioengineered. 2021;133 2710–2719.
   Google Scholar
• Solberg LB, Brorson SH, Stordalen GA, et al. Increased tartrate-resistant acid phosphatase expression in osteoblasts and osteocytes in experimental osteoporosis in rats. Calcif Tissue Int. 2014;94(5):510–521.
   PubMed Web of Science ®Google Scholar
• Sekiguchi Y, Mano H, Nakatani S, et al. Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation. Mol Med Rep. 2017;16(2):1328–1332.
   PubMed Web of Science ®Google Scholar
• Chen H, Li S, Yin H, et al. MYC-mediated miR-320a affects receptor activator of nuclear factor kappaB ligand (RANKL)-induced osteoclast formation by regulating phosphatase and tensin homolog (PTEN). Bioengineered. 2021;12(2):12677–12687.
   PubMed Web of Science ®Google Scholar
• Durbano HW, Halloran D, Nguyen J, et al. Aberrant BMP2 Signaling in Patients Diagnosed with Osteoporosis. Int J Mol Sci. 2020;21(18):6909.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhu G, Tang J, et al. C/ebpalpha controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1. J Pathol. 2018;244(3):271–282.
   PubMed Web of Science ®Google Scholar
• Fu D, Liu S, Liu J, et al. iTRAQ-based proteomic analysis of the molecular mechanisms and downstream effects of fatty acid synthase in osteosarcoma cells. J Clin Lab Anal. 2021;35(3):e23653.
   PubMed Web of Science ®Google Scholar
• Kim JH, Jeon J, Shin M, et al. Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis. Cell. 2014;156(4):730–743.
   PubMed Web of Science ®Google Scholar
• Komori T. Runx2, an inducer of osteoblast and chondrocyte differentiation. Histochem Cell Biol. 2018;149(4):313–323.
   PubMed Web of Science ®Google Scholar
• Roskoski R Jr. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res. 2012;66(2):105–143.
   PubMed Web of Science ®Google Scholar
• Pietschmann P, Mechtcheriakova D, Meshcheryakova A, et al. Immunology of osteoporosis: a mini-review. Gerontology. 2016;62(2):128–137.
   PubMed Web of Science ®Google Scholar
• Adami G, Saag KG. Osteoporosis pathophysiology, epidemiology, and screening in rheumatoid arthritis. Curr Rheumatol Rep. 2019;21(7):34.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Gao M, Liu Q, et al. Comprehensive transcriptome analysis of mesenchymal stem cells in elderly patients with osteoporosis. Aging Clin Exp Res. 2015;27(5):595–601.
   PubMed Web of Science ®Google Scholar
• Kitaura H, Marahleh A, Ohori F, et al. Osteocyte-related cytokines regulate osteoclast formation and bone resorption. Int J Mol Sci. 2020;21(14):5169.
   PubMed Web of Science ®Google Scholar
• Zhou N, Li Q, Lin X, et al. BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells. Cell Tissue Res. 2016;366(1):101–111.
   PubMed Web of Science ®Google Scholar
• Zhang N, Hu X, He S, et al. LncRNA MSC-AS1 promotes osteogenic differentiation and alleviates osteoporosis through sponging microRNA-140-5p to upregulate BMP2. Biochem Biophys Res Commun. 2019;519(4):790–796.
   PubMed Web of Science ®Google Scholar
• Miao X, Yuan J, Wu J, et al. Bone morphogenetic protein-2 promotes osteoclasts-mediated osteolysis via Smad1 and p65 signaling pathways. Spine (Phila Pa 1976). 2021;46(4):E234–E42.
   PubMed Web of Science ®Google Scholar
• Balasuriya N, McKenna M, Liu X, et al. Phosphorylation-dependent inhibition of Akt1. Genes (Basel). 2018;9(9):450.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Rotwein P. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development. Mol Cell Biol. 2012;32(2):490–500.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Carballo E, Gamez B, Ventura F. p38 MAPK signaling in osteoblast differentiation. Front Cell Dev Biol. 2016;4:40.
   PubMed Web of Science ®Google Scholar
• Koga Y, Tsurumaki H, Aoki-Saito H, et al. Roles of cyclic AMP response element binding activation in the ERK1/2 and p38 MAPK signalling pathway in central nervous system, cardiovascular system, osteoclast differentiation and mucin and cytokine production. Int J Mol Sci. 2019;20(6):1346.
   PubMed Web of Science ®Google Scholar
• Matsushita T, Chan YY, Kawanami A, et al. Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol Cell Biol. 2009;29(21):5843–5857.
   PubMed Web of Science ®Google Scholar
• Fowler TW, Kamalakar A, Akel NS, et al. Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures. J Cell Sci. 2015;128(4):683–694.
   PubMed Web of Science ®Google Scholar
• Kim K, Kim JH, Kim I, et al. Rev-erbalpha negatively regulates osteoclast and osteoblast differentiation through p38 MAPK signaling pathway. Mol Cells. 2020;43(1):34–47.
   PubMed Web of Science ®Google Scholar
• Yue L, Haroun S, Parent JL, et al. Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways. Bone. 2014;60:112–121.
   PubMed Web of Science ®Google Scholar
• Ono T, Nakashima T. Recent advances in osteoclast biology. Histochem Cell Biol. 2018;149(4):325–341.
   PubMed Web of Science ®Google Scholar
• Drake MT, Clarke BL, Oursler MJ, et al. Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned. Endocr Rev. 2017;38(4):325–350.
   PubMed Web of Science ®Google Scholar
• Lopes HB, Freitas GP, Elias CN, et al. Participation of integrin beta3 in osteoblast differentiation induced by titanium with nano or microtopography. J Biomed Mater Res A. 2019;107(6):1303–1313.
   PubMed Web of Science ®Google Scholar
• Zeng XZ, He LG, Wang S, et al. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-kappaB and NFATc1 activation and DC-STAMP expression. Acta Pharmacol Sin. 2016;37(2):255–263.
   PubMed Web of Science ®Google Scholar